Cantargia AB (publ) (STO:CANTA)
1.289
+0.009 (0.70%)
Nov 20, 2026, 5:29 PM CET
Cantargia AB Market Cap
Cantargia AB has a market cap or net worth of 363.43 million as of November 20, 2026. It is the 32,070th most valuable company in the world and the 434th biggest in Sweden. Its market cap has decreased by 53.89% in one year.
Market Cap
363.43M
Enterprise Value
141.47M
Revenue
317.31M
Global Rank
Country Rank
#434 Sweden
PE Ratio
1.93
ChartMarket Cap Chart
Since March 17, 2015, Cantargia AB's market cap has increased from 120.55M to 363.43M, an increase of 201.46%. That is a compound annual growth rate of 9.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 363.43M | -65.07% |
| Dec 30, 2025 | 1.04B | 147.63% |
| Dec 30, 2024 | 420.15M | -38.81% |
| Dec 29, 2023 | 686.62M | 33.50% |
| Dec 30, 2022 | 514.32M | -72.19% |
| Dec 30, 2021 | 1.85B | -68.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SynAct Pharma AB | 734.70M |
| Medivir AB | 701.58M |
| Oncopeptides AB | 668.43M |
| Xspray Pharma AB | 496.93M |
| FluoGuide | 482.30M |
| Sprint Bioscience AB | 400.96M |
| Corline Biomedical AB | 375.01M |
| Isofol Medical AB | 306.07M |